Hitoshi Asakura

7.2k total citations
187 papers, 5.7k citations indexed

About

Hitoshi Asakura is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Hitoshi Asakura has authored 187 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 48 papers in Hepatology and 46 papers in Surgery. Recurrent topics in Hitoshi Asakura's work include Liver Disease Diagnosis and Treatment (27 papers), Inflammatory Bowel Disease (26 papers) and T-cell and B-cell Immunology (18 papers). Hitoshi Asakura is often cited by papers focused on Liver Disease Diagnosis and Treatment (27 papers), Inflammatory Bowel Disease (26 papers) and T-cell and B-cell Immunology (18 papers). Hitoshi Asakura collaborates with scholars based in Japan, United States and United Kingdom. Hitoshi Asakura's co-authors include Takafumi Ichida, Hiroyuki Yoneyama, Yasunobu Matsuda, Kouji Matsushima, Masako Murai, Yutaka Aoyagi, Masaharu Tsuchiya, Yasufumi Suzuki, Takeshi Suda and Kazuhito Sugimura and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Hitoshi Asakura

181 papers receiving 5.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hitoshi Asakura Japan 41 1.7k 1.7k 1.4k 1.4k 1.0k 187 5.7k
K. H. Meyer zum Büschenfelde Germany 42 1.9k 1.1× 2.1k 1.3× 1.4k 1.0× 1.9k 1.4× 544 0.5× 261 6.6k
Karl‐Hermann Meyer zum Büschenfelde Germany 47 2.8k 1.6× 3.3k 2.0× 1.9k 1.3× 2.6k 1.9× 1.1k 1.0× 130 8.1k
Patricia F. Lalor United Kingdom 40 1.7k 1.0× 1.7k 1.0× 1.1k 0.8× 2.2k 1.6× 374 0.4× 90 5.6k
Kei Kashima Japan 38 1.1k 0.6× 1.6k 1.0× 1.1k 0.8× 1.1k 0.8× 343 0.3× 191 5.7k
Manuel López‐Cabrera Spain 55 1.6k 0.9× 1.3k 0.8× 2.3k 1.6× 1.1k 0.8× 384 0.4× 143 7.9k
Hiromi Ishibashi Japan 43 3.3k 1.9× 1.1k 0.6× 1.1k 0.8× 3.8k 2.8× 408 0.4× 234 6.7k
Takahiro Kodama Japan 39 1.3k 0.8× 1.3k 0.8× 2.4k 1.6× 884 0.6× 264 0.3× 176 5.8k
Jiro Fujimoto Japan 39 1.5k 0.9× 1.3k 0.8× 2.1k 1.4× 2.6k 1.9× 314 0.3× 185 7.1k
Patrick Bertolino Australia 40 1.2k 0.7× 2.9k 1.7× 1.1k 0.8× 1.2k 0.8× 382 0.4× 87 5.5k
Pilar Barrera Netherlands 36 690 0.4× 1.8k 1.1× 757 0.5× 649 0.5× 372 0.4× 97 4.6k

Countries citing papers authored by Hitoshi Asakura

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Asakura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Asakura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Asakura more than expected).

Fields of papers citing papers by Hitoshi Asakura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Asakura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Asakura. The network helps show where Hitoshi Asakura may publish in the future.

Co-authorship network of co-authors of Hitoshi Asakura

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Asakura. A scholar is included among the top collaborators of Hitoshi Asakura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Asakura. Hitoshi Asakura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takamura, Masaaki, Yoshinori Ino, Takeshi Shimamura, et al.. (2003). Expression of liver‐intestine cadherin and its possible interaction with galectin‐3 in ductal adenocarcinoma of the pancreas. Cancer Science. 94(5). 425–430. 80 indexed citations
2.
Ida, Kazunori, Junichi Okuda, Masaaki Kuroda, et al.. (2002). A REPORT FROM AN ENDOSCOPIC STUDY GROUP ON HELICOBACTER PYLORI. Acta gastro-enterologica belgica. 44(2). 183–190. 1 indexed citations
3.
Miyaji, Chikako, et al.. (2002). Unconventional NK1.1 intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease. European Journal of Immunology. 32(9). 2521–2531. 16 indexed citations
4.
Asakura, Hitoshi & Hideo Tomioka. (2002). Alkylation of Diphenyl Oxide with Long Chain Olefins Using Smectite Clay Catalysts.. NIPPON KAGAKU KAISHI. 37–46. 1 indexed citations
5.
Yoshimura, Akira, Kiyoe Ura, Hitoshi Asakura, Ryo Kominami, & Yukio Mishima. (2002). Mononucleosomes Assembled on a DNA Fragment Containing (GGA/TCC)n Repeats Can Form a DNA–DNA Complex. Biochemical and Biophysical Research Communications. 290(1). 16–22. 4 indexed citations
6.
Ichida, Takafumi, Satoshi Sugahara, Toru Ishikawa, et al.. (2002). Systemic administration of liposome‐encapsulated OK‐432 prolongs the survival of rats with hepatocellular carcinoma through the induction of IFN‐γ‐producing hepatic lymphocytes. Journal of Gastroenterology and Hepatology. 17(1). 81–90. 15 indexed citations
7.
Takeda, Yasuo, et al.. (2001). Molecular Dissection of Hepatitis C Virus Expression. Intervirology. 44(1). 21–28. 3 indexed citations
8.
Yamagiwa, Satoshi, Takafumi Ichida, Kazunari Sato, et al.. (2000). Liposome‐encapsulated OK‐432 specifically and sustainedly induces hepatic natural killer cells and intermediate T cell receptor cells. Journal of Gastroenterology and Hepatology. 15(5). 542–549. 2 indexed citations
10.
Ohkoshi, Showgo, et al.. (1995). Epidemiologic survey and genetic analysis of endemic hepatitis C virus infection in a Japanese town with a high prevalence of hepatitis B virus carriers. Journal of Medical Virology. 45(4). 367–372. 8 indexed citations
12.
Ichida, Takafumi, et al.. (1992). The study of intra-arterial injection chemotherapy with Cisplatin-Epirubicin-Lipiodol Emulsion(CELE) for hepatocellular carcinoma.. Drug Delivery System. 7(6). 423–429. 1 indexed citations
13.
Ichida, Takafumi, Masashi Kato, Masashi Watanabe, et al.. (1992). Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study. Cancer Chemotherapy and Pharmacology. 31(S1). S51–S54. 11 indexed citations
14.
Takahashi, Toru, Takehiko Abe, Takafumi Saito, et al.. (1990). PERITONEOSCOPIC FINDINGS OF ALCOHOLIC LIVER INJURY WITH SPECIAL REFERRENCE TO HISTOLOGICAL CHANGES. Acta gastro-enterologica belgica. 32(6). 1341–1353.
15.
Narisawa, Rintaro, et al.. (1990). A CASE OF DEPRESSED EARLY CARCINOMA IN THE THIRD PORTION OF THE DUODENUM. Acta gastro-enterologica belgica. 32(4). 2 indexed citations
17.
Morishita, Tetsuo, Soichiro Miura, Ricardo de Alvarenga Yoshida, et al.. (1985). CLINICAL AND ENDOSCOPIC STUDY OF EROSIONS IN DUODENAL SECOND PORTION. Acta gastro-enterologica belgica. 27(3). 1 indexed citations
18.
Asakura, Hitoshi, et al.. (1980). ENDOSCOPICAL AND HISTOPATHOLOGICAL FOLLOW-UP STUDY OF GASTRIC POLYPS. Acta gastro-enterologica belgica. 22(10). 1 indexed citations
19.
Asakura, Hitoshi, et al.. (1980). Endoscopic study on small intestinal diseases. Part 1: Macroscopic study. Acta gastro-enterologica belgica. 22(12). 1761–1769. 1 indexed citations
20.
Asakura, Hitoshi, Toshifumi Hibi∥, Tadashi Tanaka, et al.. (1978). Reevaluation of selective intraarterial prednisolone injection therapy in ulcerative colitis. 75(6). 818–825. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026